arrow
K

Kazuo Hara

aichi cancer center
H指数:70
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and Crossover Evaluation of an Artificial Intelligence-Assisted System for Solid Pancreatic Lesion Detection and Pancreatic Parenchyma Recognition in Endoscopic Ultrasonography (With Video)

人工智能辅助系统在内镜超声中检测胰腺实质病变及识别胰腺实质的开发与交叉评估(附视频)

2026-09-110
OAAI
Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic Considerations

实体瘤中多倍体巨癌细胞的治疗意义:生物学、诊断和治疗考量

Cancers
IF4.4
2026-06-010
OA
Establishment of simple pancreatic ductal adenocarcinoma identification method: S100P measurement in duodenal fluid obtained during upper gastrointestinal endoscopy

建立简单胰腺导管腺癌识别方法:上消化道内镜检查期间获取的十二指肠液中S100P的测定

2025-12-230
OAAI
Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer (vol 23, 23, 2025)

稳健的循环microRNA特征,用于胰腺癌和胆道癌的诊断与早期检测(卷23,期23,2025)

2025-04-160
OA
GLP-1R status using validated monoclonal antibody in 689 cases of neuroendocrine neoplasm and its correlation with somatostatin receptor scintigraphy, insulin production, and histological grades
2025-04-010
OAAI
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan (Dec, 10.1007/s13300-024-01675-7, 2024)

日本人群中2型糖尿病患者使用Tirzepatide 5 mg与Dulaglutide 0.75 mg治疗的长期能效比研究(Dec, 10.1007/s13300-024-01675-7, 2024)

2025-02-070
OA
Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer
2025-01-210
OAAI